7th Circuit: Allulose Zero Sugar Lawsuits Fueled By Chobani Ruling

• Nearly 60 lawsuits have been filed against food producers using allulose in products labeled as "zero sugar."
• The 7th U.S. Circuit Court of Appeals reinstated consumer deception claims against Chobani in a July ruling, impacting similar cases.
• Legal experts confirm that FDA guidance on allulose does not protect companies from state consumer protection laws.
• Allulose is a naturally occurring simple sugar with minimal calories and little impact on blood glucose.
• Companies labeling allulose products as "zero sugar" now face an extremely high risk of litigation.

The 7th Circuit's ruling has clarified that FDA guidance does not shield companies from state consumer protection laws, significantly increasing exposure to consumer deception lawsuits.

Food and beverage manufacturers are currently facing a significant wave of legal challenges concerning their use of allulose, a sugar substitute, in products marketed as containing "zero sugar." Nearly 60 lawsuits have been initiated against companies across various sectors, including producers of ice cream bars, energy drinks, gummy worms, barbecue sauces, and protein bars. These `allulose consumer deception litigation` cases allege that consumers are being misled by the "zero sugar" claims, despite the inclusion of allulose.

This surge in legal action directly follows a pivotal July decision by the 7th U.S. Circuit Court of Appeals in Chicago. The appellate court's ruling reinstated consumer deception claims against Chobani, specifically regarding its "no-sugar yogurt" assertions. This `Chobani no-sugar claim ruling` has set a precedent, signaling a heightened `zero sugar labeling risk` for any company utilizing allulose while making similar claims.

The 7th Circuit's decision has fundamentally altered the legal landscape for food producers. Previously, companies often relied on guidance from the Food and Drug Administration (FDA) as justification for excluding allulose from the total sugars calculation on nutrition labels. This interpretation effectively allowed them to market products containing allulose as "zero sugar" without perceived legal jeopardy.

However, legal experts now emphasize that the `FDA guidance allulose lawsuits` context has shifted dramatically. Laura Bentele, a partner at Armstrong Teasdale, highlighted that it is now "painfully clear" that FDA guidance does not extend to provide "additional cover" under state consumer protection laws. This means that while FDA regulations might permit certain labeling practices, they do not shield companies from state-level `food labeling consumer protection` claims alleging consumer deception. The `7th Circuit allulose zero sugar lawsuits` have thus underscored a critical distinction between federal guidance and state legal obligations.

The implications of the 7th Circuit's ruling are profound, creating an "extremely high risk" for companies that continue to label allulose-containing items as "zero sugar," according to T. Daniel Logan, a partner at Kleinfeld Kaplan Becker. This heightened exposure means that lawyers and compliance officers advising food and beverage companies must urgently review their `zero sugar` labeling for products containing allulose, as the ruling has clarified that FDA guidance does not shield companies from state consumer protection laws.

Allulose itself is a simple sugar found naturally in sources like figs and molasses. It is known for its intense sweetness while contributing minimal calories. From a physiological perspective, allulose has a small metabolic impact on the human body, with almost no effect on blood glucose levels, and is not associated with many of the negative health effects typically linked to more traditional sugars. Despite these characteristics, the legal interpretation of its inclusion in "zero sugar" products under state consumer protection statutes has now been firmly established by the recent appellate court decision.

Lawyers and compliance officers advising food and beverage companies must urgently review 'zero sugar' labeling for products containing allulose. The 7th Circuit's ruling has clarified that FDA guidance does not shield companies from state consumer protection laws, significantly increasing exposure to consumer deception lawsuits.

Source: Original reporting via Bloomberg Law